CN111297712B - Face cream composition and preparation method thereof - Google Patents

Face cream composition and preparation method thereof Download PDF

Info

Publication number
CN111297712B
CN111297712B CN202010179396.6A CN202010179396A CN111297712B CN 111297712 B CN111297712 B CN 111297712B CN 202010179396 A CN202010179396 A CN 202010179396A CN 111297712 B CN111297712 B CN 111297712B
Authority
CN
China
Prior art keywords
parts
cream composition
phase
aging
firming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010179396.6A
Other languages
Chinese (zh)
Other versions
CN111297712A (en
Inventor
张玉银
丛琳
李雪竹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai New Cogi Cosmetic Co ltd
Original Assignee
Shanghai New Cogi Cosmetic Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai New Cogi Cosmetic Co ltd filed Critical Shanghai New Cogi Cosmetic Co ltd
Priority to CN202010179396.6A priority Critical patent/CN111297712B/en
Publication of CN111297712A publication Critical patent/CN111297712A/en
Application granted granted Critical
Publication of CN111297712B publication Critical patent/CN111297712B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • A61K2800/72Hypo-allergenic

Abstract

The invention relates to the technical field of cosmetics, in particular to a face cream composition and a preparation method thereof. The cream composition is formed by the thickening agent, the polyhydric alcohol humectant, the emulsifier, the emollient, other base materials and water according to the proportion, so that the cream composition is good in use experience, moist but not sticky, mild and free of stimulation. Particularly, by adding the functional components including the anti-aging and firming component, the cream composition is not only moist and not sticky, is mild and non-irritant, but also has remarkable effects of fading fine wrinkles and firming the skin, and the aged skin can be improved and becomes firmer after long-term use. The preparation process of the cream composition is simple and easy to operate, low in cost, green and safe.

Description

Face cream composition and preparation method thereof
Technical Field
The invention relates to the technical field of cosmetics, in particular to a face cream composition and a preparation method thereof.
Background
It is well known that skin aging is classified into natural aging and aging caused by environmental factors. Generally, after 25 years old, men and women have a gradually slow metabolism of the skin and a gradually thickened stratum corneum. In addition to the effects of aging on skin conditions, changes in body hormones due to work and living stress, environmental pollution, ultraviolet radiation, poor eating habits and improper skin care methods all affect skin health, resulting in the generation of a large number of free radicals, and these active molecular groups can trigger a series of free radical reactions, causing cell damage and even death, thereby accelerating skin aging. The effective anti-aging firming skin care product is used correctly for a long time, and the skin aging speed can be effectively delayed to a certain extent.
At present, the anti-aging compact skin care products on the market are wide in types and good in quality, and even some products cannot achieve the anti-aging effect but cause skin problems such as irritation, pruritus and the like or cause sensitive skin.
Therefore, the anti-aging firming face cream which is good in use experience, moist but not sticky, mild and non-irritant, and especially has remarkable effects of fading fine wrinkles and firming skin is needed to be developed.
Disclosure of Invention
Aiming at the problems that the stickiness of the existing face cream product needs to be further reduced and the use experience needs to be further improved, the invention provides a face cream composition which is moist but not sticky, mild and free of stimulation and good in use experience, and a preparation method of the face cream composition. The anti-aging firming face cream provided by the invention is good in experience feeling, moist but not sticky, mild and non-irritant, and has remarkable effects of fading fine wrinkles and firming skin.
In order to achieve the purpose, the invention adopts the following technical scheme.
The invention provides a cream composition, which comprises the following components in percentage by mass:
3.0 to 10.0 percent of polyhydric alcohol humectant,
2.0 to 5.0 percent of emulsifier,
2.0 to 4.5 percent of thickening agent,
8.0-23.0% of an emollient,
1 to 12 percent of other base materials,
the balance of water.
Preferably, the cream composition consists of the following components in percentage by mass:
6.0 to 9.0 percent of polyhydric alcohol humectant,
3.0 to 4.5 percent of emulsifier,
2.5 to 3.8 percent of thickening agent,
14.0-19.5% of an emollient,
3.6 to 6.2 percent of other base materials,
the balance of water.
In the cream composition, the thickener is acryloyl dimethyl ammonium taurate/VP copolymer, or the acryloyl dimethyl ammonium taurate/VP copolymer and xanthan gum, hydroxyethyl cellulose, acrylic acid (esters)/C10-30 alkanol acrylate cross-linked polymer, carbomer, cetostearyl alcohol, behenyl alcohol, C12-C16 alcohol, or a mixture thereof,
Figure RE-GDA0002470939010000031
EG,
Figure RE-GDA0002470939010000032
A mixture of at least one of NS. More preferably, the thickener is acryloyl dimethyl ammonium taurate/VP copolymer, or a mixture of acryloyl dimethyl ammonium taurate/VP copolymer and at least one of xanthan gum, behenyl alcohol and cetearyl alcohol. Further preferably, the thickener consists of xanthan gum, acryloyldimethyl ammonium taurate/VP copolymer, or xanthan gum, cetearyl alcohol, acryloyldimethyl ammonium taurate/VP copolymer.
Preferably, the other base materials comprise preservatives, functional ingredients and flavor; the functional components comprise non-polyol moisturizing components and/or anti-aging and firming components. The other binder may also include a chelating agent.
The following components are respectively selected from the polyol humectant, the emulsifier, the emollient, the non-polyol humectant component, the anti-aging firming component, the chelating agent and the preservative:
the polyhydric alcohol humectant is at least one selected from dipropylene glycol, 1, 3-propanediol, glycerin, propylene glycol, 1, 3-butanediol, 1, 2-pentanediol and 1, 2-hexanediol. More preferably, the polyhydric alcohol humectant is at least one of 1, 3-butanediol, glycerol, 1, 2-hexanediol, and 1, 2-pentanediol. Further preferably, the polyhydric alcohol humectant consists of glycerin, 1, 2-pentanediol, and 1, 2-hexanediol, or consists of glycerin, 1, 3-butanediol, 1, 2-pentanediol, and 1, 2-hexanediol.
The emulsifier is selected from at least two of steareth-2, steareth-21, glyceryl stearate/PEG-100 stearate, cetearyl alcohol/cetearyl glucoside, sodium stearyl glutamate, C20-22 alcohol/C20-22 alcohol phosphate, cetearyl alcohol/cocoyl glucoside, hydrogenated lecithin, cetyl phosphate, methyl glucose sesquistearate, N-lauroyl-L-glutamic acid distearate, glyceryl stearate citrate. More preferably, the emulsifier is at least one of glyceryl stearate/PEG-100 stearate, sodium stearyl glutamate, cetearyl alcohol/cetearyl glucoside, C20-22 alcohol/C20-22 alcohol phosphate, hydrogenated lecithin. Further preferably, the emulsifier consists of sodium stearyl glutamate, cetearyl alcohol, glyceryl stearate/PEG-100 stearate, cetearyl alcohol/cetearyl glucoside, or of stearate, cetearyl alcohol/cetearyl glucoside, phytosterol canola oleate, or of sodium stearyl glutamate, glyceryl stearate/PEG-100 stearate, cetearyl alcohol/cetearyl glucoside.
Said emollient is selected from olive (Olea EUROPAEA) husk oil, isononyl isononanoate, CAMELLIA (Camellia JAPONICA) seed oil, squalane, shea butter (Butyripermum PARKII) fruit fat, pentaerythritol tetra (ethyl hexanoate), argan (Argania SPINOSA) kernel oil, tocopherol acetate, grape (VITIS VINIFERA) seed oil, cyclopenta dimethyl siloxane/cyclohexasiloxane, dimethyl siloxane/dimethiconol, and mixtures thereof,
Figure RE-GDA0002470939010000042
S, Triglyceryl (ethyl hexanoate), phytosterol canola oil glycerides, white Potentilla (LIMNANTHES ALBA) seed oil, polydimethylsiloxane, hydrogenated polyisobutene, octylmethicone, sunflower (Helianthus ANNUUS) seed oil, jojoba (Simmondsia CHINENSIS) seed oil, phytosterol/behenyl/octyldecanolAlcohol lauroyl glutamate (PS306), neopentyl glycol diheptanoate, pentaerythritol tetrakis (bis-tert-butyl hydroxyhydrocinnamate), and cyclopentadimethylsiloxane. More preferably, the emollient is selected from isononyl isononanoate, squalane, shea butter (Butyripermum PARKII), pentaerythritol tetrakis (ethyl hexanoate), and mixtures thereof,
Figure RE-GDA0002470939010000041
S, at least one of tocopherol acetate, cyclopentadimethicone/cyclohexasiloxane, dimethicone/dimethiconol, pentaerythritol tetrakis (bis-tert-butylhydroxyhydrocinnamate), jojoba (SIMMONDSIA CHINENSIS) seed oil, cyclopentadimethicone, glycerol tris (ethylhexanoate), dimethicone, and octylmethicone. Further preferably, the emollient consists of isononyl isononanoate, squalane, shea butter, pentaerythritol tetrakis (ethyl hexanoate), pentaerythritol tetrakis (di-tert-butyl hydroxyhydrocinnamate), dimethicone/dimethiconol, or octyl methicone, isononyl isononanoate, shea butter, glycerol tri (ethyl hexanoate), pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamic acid) ester, cyclopenta dimethyl silicone/cyclohexyl silicone, or isononyl isononanoate, squalane, shea butter, cyclopenta dimethyl/cyclohexasiloxane, dimethyl/dimethiconol, pentaerythritol tetrakis (di-tert-butyl hydroxyhydrocinnamic acid) ester, pentaerythritol tetrakis (ethylhexanoic acid) ester.
The non-polyalcohol moisturizing ingredient is at least one selected from sodium hyaluronate, trehalose, panthenol, betaine and mannan.
The anti-aging component is at least one selected from the group consisting of tetrahydromethylpyrimidine carboxylic acid, DERMAXYL (C12-15 alcohol benzoate/Wasabal/ceramide 2/PEG-10 phytosterol/palmitoyl hexapeptide-12/lactic acid), EYELISS (water/glycerol/hesperidin methyl chalcone/steareth-20/dipeptide-2/palmitoyl tetrapeptide-7/chlorhexidine digluconate/potassium sorbate/citric acid/sodium citrate), soluble collagen (collagen type III), collagen, coenzyme Q10, ascorbic acid, tocopherol, resveratrol, and extract of sprout of Feverca edulis.
The antiseptic is selected from at least one of caprylyl hydroximic acid, capryl glycol, methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, ethylhexyl glycerol, sodium benzoate, sodium levulinate, p-anisic acid, 1, 2-pentanediol, 1, 2-hexanediol, AGS-WM3000C, isoprene glycol, JEWEL SILVER. More preferably, the preservative is at least one selected from methyl hydroxybenzoate, phenoxyethanol, ethylhexylglycerin, propyl hydroxybenzoate, 1, 2-pentanediol, 1, 2-hexanediol and isoprene glycol.
The chelating agent is at least one selected from disodium EDTA, tetrasodium EDTA and pentasodium pentate.
By adding the functional components including the anti-aging and firming components, the anti-aging and firming cream composition disclosed by the invention is good in experience feeling, moist but not sticky, mild and non-irritant, and has remarkable effects on fading fine wrinkles and firming skin.
The preparation method of the facial cream composition of which the other base comprises the preservative comprises the following steps:
s1, dissolving the water phase materials in the polyalcohol humectant and the emulsifier, part of the preservative and part of the thickener in water to form water phase materials; if the other base material comprises a non-polyol humectant component and/or a chelating agent, then dissolving the non-polyol humectant component and/or chelating agent in water;
mixing the oil phase materials in the emollient and the emulsifier with part of the thickening agent, and heating to fully dissolve the materials to form the oil phase materials;
s2, mixing the water-phase material and the oil-phase material, uniformly stirring, and homogenizing to form a first material liquid;
s3, adding the rest materials except the other base materials, including the rest thickening agent, into the feed liquid I, homogenizing, stirring uniformly, and cooling to 40-45 ℃ to form feed liquid II;
and S4, adding the rest of the other base materials into the feed liquid II, and uniformly stirring to form the cream composition.
Further, before the thickener is mixed with other materials to form an aqueous phase material in the step S1, the thickener is subjected to a pretreatment, wherein the pretreatment is at least one selected from heating, stirring, homogenizing and soaking swelling operation.
Still further, a method for preparing the cream composition comprises the following steps:
s1, dissolving a non-polyalcohol moisturizing component, a part of preservative, a polyalcohol moisturizing component, an aqueous phase emulsifier and a pretreated thickening agent in water to form an aqueous phase material;
mixing emollient, emulsifier of oil phase and partial thickener, and heating to dissolve completely to form oil phase material;
s2, mixing the water-phase material and the oil-phase material, uniformly stirring, and then carrying out homogenization treatment to form a first material liquid;
s3, adding the rest thickening agent and the rest oil phase components except the other base materials into the feed liquid I, homogenizing, uniformly stirring, and cooling to 40-45 ℃ to form feed liquid II;
and S4, adding the rest other base materials into the material liquid II, and uniformly stirring to form the cream composition.
Compared with the prior art, the invention has the beneficial effects that:
the cream composition is formed by the thickening agent, the polyhydric alcohol humectant, the emulsifier, the emollient, other base materials and water according to the proportion, so that the cream composition is good in use experience, moist but not sticky, mild and free of stimulation. Particularly, by adding the functional components comprising the anti-aging and firming component, the cream composition is not only moist and not sticky, but also mild and non-irritant, and has remarkable effects of fading fine wrinkles and firming skin, and the aged skin can be improved and firmer after long-term use. The preparation process of the cream composition is simple and easy to operate, low in cost, green and safe.
Drawings
FIG. 1 is a graph showing the self-evaluation effect of volunteers after trying the anti-aging firming cream compositions of examples 1-3;
fig. 2 is an enlarged view of the emulsification system of the cream compositions of comparative example 4 and example 3.
Detailed Description
In order to more fully understand the technical contents of the present invention, the technical solutions of the present invention will be further described and illustrated with reference to the following specific embodiments.
Example 1
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 6 parts of glycerol, 2 parts of 1, 2-pentanediol, 0.05 part of sodium hyaluronate, 0.2 part of xanthan gum, 0.5 part of sodium stearyl glutamate, 1 part of 1, 2-hexanediol, 0.2 part of methyl hydroxybenzoate and the balance of deionized water;
phase B: isononyl isononanoate 3.5 parts, squalane 4 parts, shea butter (Butyrospermum PARKII) 2 parts, cetearyl alcohol 3 parts, pentaerythritol tetrakis (ethyl hexanoate) 2.5 parts, glyceryl stearate/PEG-100 stearate 2 parts, cetearyl alcohol/cetearyl glucoside 1.8 parts, pentaerythritol tetrakis (di-tert-butylhydroxyhydrocinnamate) 0.05 part, polydimethylsiloxane 4.5 parts, polydimethylsiloxane/dimethiconol 1.5 parts;
and C phase: 0.35 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 1 part of tetrahydromethyl pyrimidine carboxylic acid, 1.8 parts of DERMAXYL, 1 part of EYELISS, 0.5 part of soluble collagen (type III collagen) and 0.4 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the preparation method comprises the following steps:
1) and (4) performing soaking swelling pretreatment on xanthan gum and sodium hyaluronate for later use.
(in other embodiments, the pretreatment may also be at least one of heating, stirring, homogenizing, soaking in a swelling operation.)
2) Adding the material obtained in the step 1) into the weighed phase A, heating the material together until the material is fully dissolved, and stirring and mixing the materials uniformly to form a water phase material for later use.
3) Heating the weighed phase B until the material body is fully dissolved, and uniformly stirring to form an oil phase material for later use.
4) Adding the oil phase material while continuously stirring the water phase material, stirring uniformly, and homogenizing to form a material liquid I.
5) Continuously stirring the first material liquid and adding the C phase, uniformly stirring, homogenizing, and cooling to 40-45 deg.C to obtain second material liquid.
6) Sequentially adding the phase D and the phase E into the second material liquid, and uniformly stirring to form the anti-aging firming cream composition;
7) sampling the anti-aging firming cream composition obtained in the step 6), and obtaining the anti-aging firming cream after the composition is qualified by micro inspection.
Example 2
The embodiment provides an anti-aging and firming cream composition, and 100 parts by weight of the anti-aging and firming cream composition comprises the following components:
phase A: 2 parts of glycerol, 2 parts of 1, 3-butanediol, 0.02 part of sodium hyaluronate, 1.5 parts of 1, 2-pentanediol, 1.2 parts of betaine, 0.15 part of xanthan gum, 0.25 part of sodium stearyl glutamate, 0.5 part of 1, 2-hexanediol, 0.12 part of methyl hydroxybenzoate and the balance of deionized water;
phase B: octyl methicone 2 parts, isononyl isononanoate 3 parts, shea butter (Butyrospermum PARKII) 3 parts, cetearyl alcohol 2 parts, glycerol tri (ethylhexanoate) 3 parts, glycerol stearate/PEG-100 stearate 1.5 parts, cetearyl alcohol/cetearyl glucoside 1.3 parts,
Figure RE-GDA0002470939010000091
0.3 part, pentaerythritol tetrakis (bis-tert-butylhydroxyhydrocinnamate) 0.05 part, and cyclopentasiloxane/cyclohexasiloxane 4 parts;
and C phase: 0.5 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 0.5 part of tetrahydromethylpyrimidine carboxylic acid, 1.2 parts of DERMAXYL, 0.5 part of cyclobalanopsis glauca (FAGUS SYLVATICA) bud extract, 1 part of EYELISS and 0.35 part of phenoxyethanol;
e phase: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 1.
Example 3
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 5 parts of glycerol, 1.5 parts of 1, 2-pentanediol, 0.03 part of EDTA disodium, 0.1 part of xanthan gum, 0.2 part of sodium stearyl glutamate, 0.3 part of 1, 2-hexanediol, 0.12 part of methyl hydroxybenzoate and the balance of deionized water;
phase B: isononyl isononanoate 3 parts, squalane 2 parts, shea butter (butyreschermum PARKII) 1.3 parts, cetearyl alcohol 2.5 parts, pentaerythritol tetrakis (ethyl hexanoate) 2 parts, glyceryl stearate/PEG-100 stearate 2 parts, cetearyl alcohol/cetearyl glucoside 1.5 parts, pentaerythritol tetrakis (di-tert-butylhydroxyhydrocinnamate) 0.05 part, cyclopenta dimethyl siloxane/cyclohexasiloxane 3.5 parts, dimethyl siloxane/dimethiconol 1.0 part;
and C phase: 0.45 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 1.2 parts of tetrahydro-methyl pyrimidine carboxylic acid, 2.5 parts of DERMAXYL, 2 parts of collagen and 0.35 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the preparation method of the anti-aging firming cream composition of the present example is substantially the same as that of example 1, except that in step 1), since sodium hyaluronate is not added to the composition of the present example, pretreatment of sodium hyaluronate in step 1) is not required. The other steps were the same as in example 1.
Example 4
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 2.2 parts of glycerol, 0.7 part of 1, 2-pentanediol, 0.1 part of 1, 2-hexanediol, 0.03 part of EDTA disodium, 0.6 part of xanthan gum, 0.02 part of methyl hydroxybenzoate, 0.12 part of sodium stearyl glutamate and the balance of deionized water (83.94 parts);
phase B: 1 part of glyceryl stearate/PEG-100 stearate, 0.9 part of cetearyl alcohol/cetearyl glucoside, 1.88 parts of isononyl isononanoate, 1.24 parts of squalane, 0.81 part of shea butter (Butyrschum PARKII), 0.62 part of polydimethylsiloxane/dimethiconol; 0.03 part of pentaerythritol tetra (bis-tert-butyl hydroxyhydrocinnamate), 1.25 parts of pentaerythritol tetra (ethylhexanoate), 2.17 parts of cyclopentadimethicone/cyclohexasiloxane and 1.64 parts of cetostearyl alcohol;
and C phase: 0.3 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 0.4 part of DERMAXYL, 0.32 part of collagen, 0.19 part of tetrahydro-methyl pyrimidine carboxylic acid and 0.05 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 3.
Example 5
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 4.7 parts of glycerol, 15 parts of 1, 2-pentanediol, 0.3 part of 1, 2-hexanediol, 0.04 part of EDTA disodium, 0.08 part of xanthan gum, 0.07 part of methyl hydroxybenzoate, 0.2 part of sodium stearyl glutamate and the balance of deionized water;
phase B: glyceryl stearate/PEG-100 stearate 1.8 parts, cetearyl alcohol/cetearyl glucoside 1 part, isononyl isononanoate 3.29 parts, squalane 2.18 parts, shea butter (Butyrum PARKII) 1.41 parts, dimethicone/dimethiconol 1.09 parts; 0.05 part of pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamate), 2.17 parts of pentaerythritol tetra (ethyl hexanoate), 3.81 parts of cyclopenta dimethyl silicone/cyclohexasiloxane and 2.05 parts of cetearyl alcohol;
and C phase: 0.37 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 1.42 parts of DERMAXYL, 1.12 parts of collagen, 0.7 part of tetrahydro-methyl pyrimidine carboxylic acid and 0.2 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 3.
Example 6
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 6.5 parts of glycerol, 2 parts of 1, 2-pentanediol, 0.53 part of 1, 2-hexanediol, 0.07 part of EDTA disodium, 0.13 part of xanthan gum, 0.12 part of methyl hydroxybenzoate, 0.3 part of sodium stearyl glutamate and the balance of deionized water;
phase B: 3 parts of glyceryl stearate/PEG-100 stearate, 1.2 parts of cetearyl alcohol/cetearyl glucoside, 4.28 parts of isononyl isononanoate, 3.03 parts of squalane, 1.97 parts of fruit fat of Butyrospermum PARKII (Butyrrhiza PARKII), and 1.52 parts of polydimethylsiloxane/dimethiconol; 0.08 part of pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamate), 3.31 parts of pentaerythritol tetra (ethyl hexanoate), 5.31 parts of cyclopenta dimethyl silicone/cyclohexasiloxane and 3.11 parts of cetearyl alcohol;
and C phase: 0.56 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 2.48 parts of DERMAXYL, 1.98 parts of collagen, 1.2 parts of tetrahydro-methyl pyrimidine carboxylic acid and 0.3 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 3.
Example 7
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 7 parts of glycerol, 2 parts of 1, 2-pentanediol, 1 part of 1, 2-hexanediol, 0.08 part of EDTA disodium, 0.14 part of xanthan gum, 0.23 part of methyl hydroxybenzoate, 0.3 part of sodium stearyl glutamate and the balance of deionized water;
phase B: 2.6 parts of glyceryl stearate/PEG-100 stearate, 2.1 parts of cetearyl alcohol/cetearyl glucoside, 5.37 parts of isononyl isononanoate, 3.58 parts of squalane, 2.33 parts of shea butter (Butyripermum PARKII), and 1.79 parts of polydimethylsiloxane/dimethiconol; 0.09 part of pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamate), 3.58 parts of pentaerythritol tetra (ethyl hexanoate), 6.26 parts of cyclopenta dimethyl silicone/cyclohexasiloxane and 3.69 parts of cetearyl alcohol;
and C phase: 0.67 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 4.8 parts of DERMAXYL, 3.84 parts of collagen, 2.3 parts of tetrahydro-methyl pyrimidine carboxylic acid and 0.7 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 3.
Example 8
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 5 parts of glycerol, 1.5 parts of 1, 2-pentanediol, 0.3 part of 1, 2-hexanediol, 0.03 part of EDTA disodium, 0.1 part of acryloyl dimethyl taurate/VP copolymer, 0.12 part of methyl hydroxybenzoate, 0.2 part of stearyl sodium glutamate and the balance of deionized water;
phase B: 2 parts of glyceryl stearate/PEG-100 stearate, 1.5 parts of cetearyl alcohol/cetearyl glucoside, 3 parts of isononyl isononanoate, 2 parts of squalane, 1.3 parts of fruit fat of Butyrospermum PARKII (Butyrrhiza PARKII), and 1.0 part of polydimethylsiloxane/dimethiconol; 0.05 part of pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamate), 2 parts of pentaerythritol tetra (ethyl hexanoate), 3.5 parts of cyclopenta dimethyl siloxane/cyclohexasiloxane and 2.5 parts of cetearyl alcohol;
and C phase: 0.45 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 2.5 parts of DERMAXYL, 2 parts of collagen, 1.2 parts of tetrahydro-methyl pyrimidine carboxylic acid and 0.35 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the preparation method of the anti-aging and firming cream composition of the present example is substantially the same as that of example 1, except that step 1), since sodium hyaluronate and xanthan gum are not added to the composition of the present example, the step 1) is not required. The other steps were the same as in example 1.
Example 9
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 5 parts of glycerol, 1.5 parts of 1, 2-pentanediol, 0.3 part of 1, 2-hexanediol, 0.03 part of EDTA disodium, 0.1 part of acryloyl dimethyl taurate/VP copolymer, 0.12 part of methyl hydroxybenzoate, 0.2 part of stearyl sodium glutamate and the balance of deionized water;
phase B: 2 parts of glyceryl stearate/PEG-100 stearate, 1.5 parts of cetearyl alcohol/cetearyl glucoside, 3 parts of isononyl isononanoate, 2 parts of squalane, 1.3 parts of fruit fat of Butyrospermum PARKII (Butyrrhiza PARKII), and 1.0 part of polydimethylsiloxane/dimethiconol; 0.05 part of pentaerythritol tetra (di-tert-butyl hydroxyhydrocinnamate), 2 parts of pentaerythritol tetra (ethyl hexanoate), 3.5 parts of cyclopentadimethicone/cyclohexasiloxane and 2.5 parts of acryloyl dimethyl taurate/VP copolymer;
and C phase: 0.45 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 2.5 parts of DERMAXYL, 2 parts of collagen, 1.2 parts of tetrahydro-methyl pyrimidine carboxylic acid and 0.35 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the preparation method of the anti-aging and firming cream composition of the present example is substantially the same as that of example 1, except that step 1), since sodium hyaluronate and xanthan gum are not added to the composition of the present example, the step 1) is not required. The other steps were the same as in example 1.
Example 10
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 5 parts of glycerol, 1.5 parts of 1, 2-pentanediol, 0.3 part of 1, 2-hexanediol, 0.03 part of EDTA disodium, 0.1 part of behenyl alcohol, 0.12 part of methyl hydroxybenzoate, 0.2 part of sodium stearyl glutamate and the balance of deionized water;
phase B: glyceryl stearate/PEG-100 stearate 2 parts, cetearyl alcohol/cetearyl glucoside 1.5 parts, isononyl isononanoate 3 parts, squalane 2 parts, shea butter (Butyrum PARKII) 1.3 parts, dimethicone/dimethiconol 1.0 part; 0.05 part of pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamate), 2 parts of pentaerythritol tetra (ethyl hexanoate), 3.5 parts of cyclopentadimethicone/cyclohexasiloxane and 2.5 parts of cetostearyl alcohol;
and C phase: 0.45 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 2.5 parts of DERMAXYL, 2 parts of collagen, 1.2 parts of tetrahydro-methyl pyrimidine carboxylic acid and 0.35 part of phenoxyethanol;
e phase: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 1.
The preparation method of the anti-aging and firming cream composition of the present embodiment is substantially the same as that of embodiment 1, except that step 1), since sodium hyaluronate and xanthan gum are not added to the composition of the present embodiment, and behenyl alcohol is added to the composition of the present embodiment, the sodium hyaluronate and xanthan gum do not need to be pretreated in step 1), and behenyl alcohol is subjected to heating pretreatment. The other steps were the same as in example 1.
Example 11
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 5 parts of glycerol, 1.5 parts of 1, 3-butanediol, 0.3 part of 1, 2-hexanediol, 0.03 part of EDTA disodium, 0.1 part of xanthan gum, 0.12 part of methyl hydroxybenzoate, 0.2 part of sodium stearyl glutamate and the balance of deionized water;
phase B: 2 parts of glyceryl stearate/PEG-100 stearate, 1.5 parts of C20-22 alcohol/C20-22 alcohol phosphate, 3 parts of isononyl isononanoate, 2 parts of squalane, 1.3 parts of fruit fat of Butyrospermum PARKII (Butyrspermum PARKII) and 1.0 part of polydimethylsiloxane/dimethiconol; 0.05 part of pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamate), 2 parts of pentaerythritol tetra (ethyl hexanoate), 3.5 parts of cyclopenta dimethyl siloxane/cyclohexasiloxane and 2.5 parts of cetearyl alcohol;
and C phase: 0.45 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 2.5 parts of DERMAXYL, 2 parts of collagen, 1.2 parts of tetrahydro-methyl pyrimidine carboxylic acid and 0.35 part of phenoxyethanol;
phase E: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 3.
Example 12
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 5 parts of glycerol, 1.8 parts of 1, 2-pentanediol, 0.03 part of EDTA disodium, 0.1 part of xanthan gum, 0.12 part of methyl hydroxybenzoate, 0.2 part of sodium stearyl glutamate and the balance of deionized water;
phase B: 1 part of C20-22 alcohol/C20-22 alcohol phosphate, 1 part of hydrogenated lecithin, 1.5 parts of cetearyl alcohol/cetearyl glucoside, 3 parts of isononyl isononanoate, 2 parts of squalane, 1.3 parts of fruit fat of Butyrospermum PARKII (Butyrspermum PARKII), and 1.0 part of polydimethylsiloxane/dimethiconol; 0.05 part of pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamate), 2 parts of pentaerythritol tetra (ethyl hexanoate), 3.5 parts of cyclopentadimethicone/cyclohexasiloxane and 2.5 parts of cetostearyl alcohol;
and C phase: 0.45 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 2.5 parts of DERMAXYL, 2 parts of collagen, 1.2 parts of tetrahydromethyl pyrimidine carboxylic acid and 0.35 part of phenoxyethanol;
e phase: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 3.
Example 13
The embodiment provides an anti-aging firming cream composition, wherein 100 parts by weight of the anti-aging firming cream composition comprises the following components:
phase A: 5 parts of glycerol, 1.5 parts of 1, 2-pentanediol, 0.03 part of EDTA disodium, 0.1 part of xanthan gum, 0.2 part of sodium stearyl glutamate, 0.3 part of 1, 2-hexanediol, 0.12 part of propyl hydroxybenzoate and the balance of deionized water;
phase B: isononyl isononanoate 3 parts, squalane 2 parts, jojoba (SIMMONDSIA CHINENSIS) seed oil 1.3 parts, cetostearyl alcohol 2.5 parts, tocopherol acetate 1 part, glycerol tris (ethylhexanoate) 1 part, glyceryl stearate/PEG-100 stearate 2 parts, cetostearyl alcohol/cetostearyl glucoside 1.5 parts, pentaerythritol tetrakis (di-tert-butyl hydroxyhydrocinnamate) ester 0.05 part, cyclopenta dimethylsiloxane 3.5 parts, polydimethylsiloxane 0.5 part, octyl methicone 0.5 part;
and C phase: 0.45 part of acryloyl dimethyl ammonium taurate/VP copolymer;
phase D: 1.2 parts of tetrahydromethyl pyrimidine carboxylic acid, 2.5 parts of DERMAXYL, 2 parts of collagen and 0.35 part of isoprene glycol;
e phase: 0.05 part of spice essence;
the anti-aging firming cream composition of this example was prepared in the same manner as in example 3.
Comparative example 1
This comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 for 100 parts by weight of the cream composition of this comparative example: the composition is not added with anti-aging and anti-compacting component DERMAXYL, i.e. no DERMAXYL is added in the D phase, and the rest is the same. The preparation method was the same as in example 3.
Comparative example 2
This comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 for 100 parts by weight of the cream composition of this comparative example: the emulsifier in phase B was 1.5 parts cetearyl alcohol/cetearyl glucoside, glycerol free stearate/PEG-100 stearate, all other things being equal. The preparation method was the same as in example 3.
Comparative example 3
The present comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 by 100 parts by weight, in that: the composition is not added with acryloyl dimethyl ammonium taurate/VP copolymer, the thickening agent in the phase A is xanthan gum, the thickening agent in the phase B is cetostearyl alcohol, and the composition is free of phase C and is consistent with other components.
The preparation method correspondingly reduces C-phase feeding operation, namely mixing water-phase materials and oil-phase materials to form a first material liquid, cooling to 40-45 ℃, sequentially adding the D phase and the E phase into the first material liquid, and uniformly stirring to form the cream composition.
Comparative example 4
This comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 for 100 parts by weight of the cream composition of this comparative example: no emulsifier sodium stearyl glutamate is contained in phase A, and the others are consistent. The preparation method was the same as in example 3.
Comparative example 5
The present comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 by 100 parts by weight, in that: in phase A, emulsifier sodium stearyl glutamate and preservative methyl hydroxybenzoate are not contained, and the others are consistent. The preparation method was the same as in example 3.
Comparative example 6
This comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 for 100 parts by weight of the cream composition of this comparative example: pentaerythritol tetrakis (bis-tert-butylhydroxyhydrocinnamate) was absent from phase B, and the others were identical. The preparation method was the same as in example 3.
Comparative example 7
The present comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 by 100 parts by weight, in that: phase B was replaced with polysorbate 81 instead of glyceryl stearate/PEG-100 stearate, the others being identical. The preparation method was the same as in example 3.
Comparative example 8
This comparative example provides a cream composition having a composition different from that of the anti-aging firming cream composition of example 3 for 100 parts by weight of the cream composition of this comparative example: in phase C, carbomer was used in place of the ammonium acryloyldimethyltaurate/VP copolymer, the others being identical. The preparation method is also the same as that of example 3.
Comparative example 9
This comparative example provides a cream composition having a composition different from that of the cream composition of comparative example 3 for 100 parts by weight of the cream composition of the comparative example: the amount of xanthan gum in phase a was increased to 0.5 parts. The preparation method is also the same as that of example 3.
Comparative example 10
This comparative example provides a cream composition having a composition different from that of the cream composition of comparative example 3 for 100 parts by weight of the cream composition of the comparative example: in phase B, 2, 6-di-tert-butyl-4-methylphenol is used to replace pentaerythritol tetrakis (bis-tert-butyl hydroxyhydrocinnamate). The preparation method is also the same as in example 3.
The anti-aging firming creams prepared in examples 1-13 were provided to volunteers for 4-week use. Samples 1-13 are combination 1 (example 1+ example 2), combination 2 (example 1+ example 3), combination 3 (example 2+ example 3), combination 4 (example 3+ example 4), combination 5 (example 3+ example 5), combination 6 (example 3+ example 6), combination 7 (example 3+ example 7), combination 8 (example 3+ example 8), combination 9 (example 3+ example 9), combination 10 (example 3+ example 10), combination 11 (example 3+ example 11), combination 12 (example 3+ example 12), combination 13 (example 3+ example 13), respectively; 10 volunteers, male and female, normal skin were randomly selected for each sample.
The using method comprises the following steps: the anti-aging firming face cream in the sample is used for half face after face cleaning.
After the trial, the volunteers score according to the evaluation indexes. The evaluation index is shown in the following table, and the index evaluation maximum score of 5, and the larger the numerical value, the higher the degree of the corresponding index, or the better the mildness.
Figure RE-GDA0002470939010000221
After the end of the trial, the evaluation results (average values) of the volunteers on the anti-aging firming creams prepared in examples 1 to 13 are shown in the following table.
Figure RE-GDA0002470939010000222
Figure RE-GDA0002470939010000231
The self-evaluation effect graphs of the volunteers of the anti-aging firming cream compositions of the embodiments 1-3 are shown in fig. 1, and according to feedback of the volunteers and the test results, the cream composition disclosed by the invention is good in use experience, moist but not sticky, mild and non-irritant, has remarkable effects on fading fine wrinkles and firming skin, and enables aged skin to be improved and become firmer.
The product of the cream composition of example 3 has relatively optimal skin feel and efficacy, and is moist and non-sticky during use.
The cream composition of comparative example 1 was provided to volunteers in the same manner. Since the functional component DERMAXYL was not added to the cream composition of comparative example 1, the skin anti-aging effect was found to be less significant after a long-term use. By adding the DERMAXYL component, the main active component palmitoyl hexapeptide-12 in the DERMAXYL has similar substances capable of inhibiting nerve conduction, blocking conduction function between nerve muscles, avoiding excessive muscle contraction, relieving muscle contraction force, relaxing muscles, reducing dynamic wrinkles, eliminating fine wrinkles and preventing fine wrinkles from forming; effectively reorganizes the elasticity of collagen, can increase the activity of elastin, relaxes the lines of the face, and smoothes wrinkles and improves laxity.
The cream composition of comparative example 2 did not have the glyceryl stearate/PEG-100 stearate emulsifier added, resulting in insufficient emulsifier in the formulation to emulsify the entire oil and eventually oil-water separation, failing the stability test. A good product must be subjected to stringent stability tests before it can be marketed. The material stability test generally comprises high temperature (40-50 ℃), low temperature (minus 10-minus 18 ℃), light stability test and high and low temperature alternating and cold cycle test, and the stability of the material is qualified when the material is not discolored, not layered or thickened for 3-6 months. While it may be possible to make a stable product using other emulsifiers, the skin feel of the product may be affected, as in comparative example 7, when polysorbate 81 is substituted for the glyceryl stearate/PEG-100 stearate in phase B of example 3, the stability of the cream composition of comparative example 7 is acceptable, but the slimy feel is evident and the skin feel is poor compared to the cream composition of example 3.
The cream composition of comparative example 3 had no added ammonium acryloyldimethyltaurate/VP copolymer and the consistency of the product was not sufficient to achieve the cream texture. If the ammonium acryloyldimethyltaurate/VP copolymer is replaced by other thickening agents, such as the comparative example 8, and carbomer is used for replacing the ammonium acryloyldimethyltaurate/VP copolymer, not only the skin feel is affected and the slimy feel is obviously increased (the slimy feel is evaluated by the evaluation method, and the slimy feel is 3.1), but also the addition of raw materials with ionic properties (such as general extract functional ingredients) is limited due to the stability problem. As in comparative example 9, no acrylamide/VP copolymer was added, and the amount of xanthan gum used in the cream composition was increased to 0.5 parts, and although the product of comparative example 9 produced a cream texture, the skin feel was poor, and the product felt sticky during use (evaluated by the above evaluation method, and a sticky feel score of 2.9), whereas the good cream product was very contraindicated for sticky feel. However, when the composition uses the ammonium acryloyldimethyl taurate/VP copolymer as the thickener, a small amount of xanthan gum is added, so that the thickening is assisted, the stability of the product can be improved, the skin feel of the product can be improved, and the sticky feel can be reduced, for example, in the cream compositions of examples 3 and 8-10, the cream composition of example 3 is moist and not sticky in the using process, and the skin feel is better than that of examples 8-10.
Compared with the cream composition in the embodiment 3, the cream composition in the embodiment 4 has poor skin feeling (evaluated by the evaluation method, the ductility score is 3.9, the greasy feeling score is 2.7, the absorption speed is 4.3, the moisture retention is 4.1 min, the moisture is 3.8, the tightening effect is 4, the fine line fading effect is 4.1 min, and the mildness is 4.3 min) compared with the cream composition in the embodiment 3 in which sodium stearyl glutamate is not added, namely, the skin feeling can be effectively improved by adding a small amount of sodium stearyl glutamate, the system is helped to form a liquid crystal structure, the slow release effect on the functional components in the formula is achieved to a certain extent, and the bioavailability of the functional components is improved. Meanwhile, the addition of a small amount of sodium stearyl glutamate is helpful to make the emulsified particle size of the system smaller and the stability of the system better, as shown in fig. 2, the left a is a control group (comparative example 4), the right b is a group added with 0.2 wt% of sodium stearyl glutamate (example 3), and the emulsified particle size of b is smaller and more dispersed.
Comparative example 5 no methylparaben was added and the cream composition of comparative example 5 failed the fungal test as detected by the preservative challenge microorganisms. The methyl hydroxybenzoate in the formula can pass a corrosion prevention challenge test when the addition amount exceeds 0.12%, but long-term experimental tests show that the addition amount is preferably not more than 0.2 wt% in the product, otherwise potential risks such as irritation are brought, and the addition amount is reduced as far as possible under the condition of preventing the product from rotting and deteriorating. Some of the traditional preservatives in the preservative list may have better and cheaper preservative effect, but the traditional preservatives are not high in mildness or have potential carcinogenic risks, and the like, if the traditional preservatives in the non-preservative list can have preservative effect, the cost is greatly increased, for example, 1, 2-hexanediol has preservative effect, but is not suitable for being used alone, the cost is too high, the irritation of the product is greatly increased if the dosage exceeds 0.5 wt%, and in addition, the product independently uses 1, 2-hexanediol as the preservative, and even if the dosage is 0.5 wt%, the product cannot pass the preservative challenge microorganism test. Therefore, the anticorrosion system of the formula of the cosmetic generally needs reasonable compounding of a plurality of components, and meets the declared requirements of products or cost limiting conditions and the like.
Comparative example 6 pentaerythritol tetrakis (bis-tert-butylhydroxyhydrocinnamate) was not added, the oxidative deterioration of oil in the product was retarded to some extent, vegetable oil in the formula was generally very easy to be oxidized, rancid and the like, for example, the fruit fat of Butyrospermum PARKII (Butyrospermum PARKII) in the formula is a component which is relatively easy to be oxidized, and if pentaerythritol tetrakis (bis-tert-butylhydroxyhydrocinnamate) was not added in the formula, the product was found to be more discolored than the product with pentaerythritol tetrakis (bis-tert-butylhydroxyhydrocinnamate) in the stability test, and the comparison was obvious around 2-3 months. In addition, 2, 6-di-tert-butyl-4-methylphenol can also delay the oxidative deterioration of oil in the product, but the effect of pentaerythritol tetra (bis-tert-butyl hydroxy hydrocinnamic acid) ester is relatively better through comparison tests, and the color of the product changes within 3 months in a high temperature (40-50 ℃) stability test like the cream composition of comparative example 10.
The technical contents of the present invention are further illustrated by the examples, so as to facilitate the understanding of the reader, but the embodiments of the present invention are not limited thereto, and any technical extension or re-creation based on the present invention is protected by the present invention.

Claims (6)

1. The cream composition is characterized by comprising the following components in percentage by mass:
3.0 to 10.0 percent of polyhydric alcohol humectant,
2.0 to 5.0 percent of emulsifier,
2.0 to 4.5 percent of thickening agent,
8.0-23.0% of emollient,
1-12% of other base materials,
the balance of water;
the thickening agent consists of xanthan gum and acryloyl dimethyl ammonium taurate/VP copolymer, or consists of xanthan gum, cetearyl alcohol and acryloyl dimethyl ammonium taurate/VP copolymer;
the emulsifier consists of sodium stearyl glutamate, cetearyl alcohol, glyceryl stearate/PEG-100 stearate, cetearyl alcohol/cetearyl glucoside, or consists of stearate, cetearyl alcohol/cetearyl glucoside, phytosterol canola oleate, or consists of sodium stearyl glutamate, glyceryl stearate/PEG-100 stearate, cetearyl alcohol/cetearyl glucoside;
the emollient is composed of isononyl isononanoate, squalane, shea butter, pentaerythritol tetra (ethyl hexanoate), pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamic acid) ester, polydimethylsiloxane/dimethiconol, or octyl methicone, isononyl isononanoate, shea butter, glycerol tri (ethyl hexanoate), pentaerythritol tetra (di-tert-butyl hydroxy hydrocinnamic acid) ester, cyclopenta dimethyl silicone/cyclohexyl silicone, or isononyl isononanoate, squalane, shea butter, cyclopenta dimethyl/cyclohexasiloxane, dimethyl/dimethiconol, pentaerythritol tetrakis (di-tert-butyl hydroxyhydrocinnamic acid) ester, pentaerythritol tetrakis (ethylhexanoic acid) ester.
2. The cream composition according to claim 1, which is characterized by comprising the following components in percentage by mass:
6.0 to 9.0 percent of polyhydric alcohol humectant,
3.0 to 4.5 percent of emulsifier,
2.5 to 3.8 percent of thickening agent,
14.0-19.5% of an emollient,
3.6 to 6.2 percent of other base materials,
the balance of water.
3. A cream composition according to claim 1 or claim 2, wherein the polyhydric alcohol humectant is selected from at least one of dipropylene glycol, 1, 3-propanediol, glycerine, propylene glycol, 1, 3-butanediol, 1, 2-pentanediol, 1, 2-hexanediol.
4. A cream composition according to claim 1 or 2, wherein the other bases comprise preservatives, functional ingredients and perfume flavours; the functional components comprise non-polyol moisturizing components and/or anti-aging and firming components.
5. The cream composition of claim 4, wherein the moisturizing ingredient is selected from at least one of sodium hyaluronate, trehalose, panthenol, betaine, and mannan; the anti-aging and anti-firming component is at least one selected from the group consisting of tetrahydro-methyl pyrimidine carboxylic acid, DERMAXYL, EYELISS, collagen type III, collagen, coenzyme Q10, ascorbic acid, tocopherol, resveratrol, and extract of cyclobalanopsis glauca bud; the preservative is at least one selected from caprylyl hydroximic acid, capryl glycol, methyl hydroxybenzoate, propyl hydroxybenzoate, phenoxyethanol, ethylhexyl glycerol, sodium benzoate, sodium levulinate, p-anisic acid, 1, 2-pentanediol, 1, 2-hexanediol, AGS-WM3000C, isoprene glycol and JEWEL SILVER, and the chelating agent is at least one selected from disodium EDTA, tetrasodium EDTA and pentasodium pentetate.
6. A method of preparing the cream composition of claim 4, comprising the steps of:
s1, dissolving the water phase materials in the polyalcohol humectant and the emulsifier, part of the preservative and part of the thickener in water to form water phase materials; if the other base stock comprises non-polyol moisturizing ingredients, dissolving the non-polyol moisturizing ingredients in water as well;
mixing the oil phase materials in the emollient and the emulsifier with part of the thickening agent, and heating to fully dissolve the materials to form the oil phase materials;
s2, mixing the water-phase material and the oil-phase material, uniformly stirring, and homogenizing to form a first material liquid;
s3, adding the rest materials except the other base materials, including the rest thickening agent, into the material liquid I, homogenizing, stirring uniformly, and cooling to 40-45 ℃ to form a material liquid II;
s4, adding the rest other base materials into the material liquid II, and uniformly stirring to form the cream composition.
CN202010179396.6A 2020-03-13 2020-03-13 Face cream composition and preparation method thereof Active CN111297712B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010179396.6A CN111297712B (en) 2020-03-13 2020-03-13 Face cream composition and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010179396.6A CN111297712B (en) 2020-03-13 2020-03-13 Face cream composition and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111297712A CN111297712A (en) 2020-06-19
CN111297712B true CN111297712B (en) 2022-09-06

Family

ID=71162532

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010179396.6A Active CN111297712B (en) 2020-03-13 2020-03-13 Face cream composition and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111297712B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110882174A (en) * 2019-12-27 2020-03-17 广州环亚化妆品科技有限公司 Moisturizing emulsion and preparation method thereof
FR3114024B1 (en) * 2020-09-11 2022-09-09 Fabre Pierre Dermo Cosmetique New emulsion that mimics the skin
CN112691070A (en) * 2021-01-27 2021-04-23 深圳市琉璃光生物科技有限公司 Anti-aging composition, eye cream and preparation method thereof
CN113476356A (en) * 2021-04-30 2021-10-08 云南英格生物技术有限公司 Preparation method and application of pyracantha fortuneana fruit extract
CN114917153B (en) * 2021-07-15 2024-02-27 上海和宣舒实业有限公司 Tender powder and preparation method thereof
CN113749972B (en) * 2021-10-18 2022-09-20 上海新高姿化妆品有限公司 Composition with anti-wrinkle effect and application of composition in cosmetics
CN113786353B (en) * 2021-11-03 2023-03-14 广州欧正化妆品技术研究院有限公司 Cream containing DNA sodium anti-aging combined factor and preparation method thereof
CN113876641A (en) * 2021-11-05 2022-01-04 上海新高姿化妆品有限公司 Cosmetic composition with anti-wrinkle and firming effects and application thereof
CN114668688A (en) * 2022-03-23 2022-06-28 广州市白云区大荣精细化工有限公司 Waterproof face beautifying cream and preparation method thereof
CN114632028B (en) * 2022-03-30 2023-09-05 广州优肌源化妆品有限公司 Lifting and tightening cream and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107669500A (en) * 2017-11-28 2018-02-09 广州市花安堂生物科技有限公司 A kind of moisturizing elite breast and preparation method thereof
CN107693433A (en) * 2017-11-13 2018-02-16 广州市花安堂生物科技有限公司 A kind of moisturizing elite and preparation method thereof
CN108524377A (en) * 2018-07-05 2018-09-14 上海新高姿化妆品有限公司 A kind of lightening compositions and its face cream
CN109363997A (en) * 2018-12-21 2019-02-22 广州欧盛化妆品有限公司 A kind of deep water supplement moisturiser and preparation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107693433A (en) * 2017-11-13 2018-02-16 广州市花安堂生物科技有限公司 A kind of moisturizing elite and preparation method thereof
CN107669500A (en) * 2017-11-28 2018-02-09 广州市花安堂生物科技有限公司 A kind of moisturizing elite breast and preparation method thereof
CN108524377A (en) * 2018-07-05 2018-09-14 上海新高姿化妆品有限公司 A kind of lightening compositions and its face cream
CN109363997A (en) * 2018-12-21 2019-02-22 广州欧盛化妆品有限公司 A kind of deep water supplement moisturiser and preparation method

Also Published As

Publication number Publication date
CN111297712A (en) 2020-06-19

Similar Documents

Publication Publication Date Title
CN111297712B (en) Face cream composition and preparation method thereof
KR101420599B1 (en) Compositions containing anti-acne agents and the use thereof
CN108542870B (en) Mild soothing infant face cream
US20190021961A1 (en) Water-in-oil emulsion
EP2281549A1 (en) Cosmetic compositions with long lasting skin moisturizing properties
CN111956591A (en) Anti-allergy, soothing and skin color improving cosmetic composition and preparation method thereof
CN113057902B (en) Oil tea seed oil facial cream containing hydrolyzed vegetable protein and preparation method thereof
CN112569133A (en) Firming and anti-wrinkle essence cream and preparation method thereof
EP3806820A1 (en) Cosmetic preparation against acne
KR20120070192A (en) Low viscous o/w cosmetic composition having improved cosmetics formulation stability and safety
EP2253305A2 (en) Skin treatment for pore refinement
KR20180109329A (en) Cosmetic composition containing moisturizing complex
CN113081906A (en) Astaxanthin composition and preparation method and application thereof
KR20110035516A (en) O/w cosmetic composition having improved cosmetics formulation stability
US20030031688A1 (en) Cosmetic composition with improved skin moisturizing properties
CN112353705B (en) Cosmetic composition, preparation method thereof and cosmetic with wrinkle removing and aging delaying effects
US20180360712A1 (en) Cosmetic composition and use thereof
KR101532938B1 (en) Water-in-Oil Type Emulsified Cosmetic Composition Containing High Content Butter
CN112754963A (en) Application method of firming anti-wrinkle skin care product
JP2002511428A (en) Glycolipid cream
CN109562136A (en) It treats skin disorder or mitigates the method for skin disorder seriousness
WO2020104092A1 (en) Oil-containing facial care preparation
CN114159333B (en) Myobase liquid and preparation method thereof
EP0680748B1 (en) Cosmetic and/or dermatological composition containing a cationic polymeric gelling agent and its uses especially for skin depigmentation
EP2825211A1 (en) Cosmetic composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant